Jun Wang

Jun Wang is a Senior Research Scientist I at Promega Corporation since October 2014, specializing in the development of target cells for ADCC reporter bioassays and killing assays related to SARS-CoV-2 therapeutic drugs and vaccine development. Previous roles include Research Scientist at Promega, where Jun built reporter-based bioassays for immune receptors and led the scientific commercialization of these bioassays. Earlier experience includes Technical Application Scientist at Cellular Dynamics International, focusing on product commercialization of iCell® products, and Scientist at Life Technologies, where Jun led programs in custom antibody labeling and generated stable cell lines. Jun holds a Master's Degree in Entomology from the University of Wisconsin-Madison and two Master's Degrees in Microbiology and Molecular Biology from Xiamen University, where a Bachelor's Degree in Microbiology was also obtained.